Utepreva is the first endometrial biopsy sampler to detect endometrial cancer before symptoms appear. Utepreva officially launched at ACOG Conference 2026 in DC.
About
Services
AUDIENCE SEGMENTATION
BRAND STRATEGY
brand messaging
WEBSITE content development
launch activation
the ask
Utepreva is an endometrial cancer detection device built on a hard truth: too many women are diagnosed too late.
Founded by a surgeon who saw the gap firsthand, it gives clinicians earlier answers — so patients reach them while more treatment options are possible. Their founding team asked us to develop and launch a brand system that speaks to doctors with precision, warmth, and practicality, while never flinching from what’s at stake for women’s lives.
Section Styles full-width
Strategy
Making early the standard
At the heart of the brand is a reframe: early detection isn't about fear, it's about possibility. Utepreva sells to clinicians, so every word has to earn clinical trust — precise, evidence-backed, regulatory-sound — without losing the human weight of the work. The result is a voice that's honest and unflinching but always uplifting: the tool that helps you catch what others miss.
Project and client teams
HEad of brand: Shauna Faulisi
Co-FOUNDER: Dr. Jeanetta Stega.
CO-FOUNDER: Dr. Damian Stega
COMMERCIAL LEAD: Peter Faulisi
Studio: Vitamin Pack
Creative Director: Angela Goleme
Design Director: Patrick Allison
Brand strategist: Menaka Iyer
“We were amazed by the way Menaka and the Vitamin Pack team threaded the needle between our clinical and business goals — while creating a brand that will resonate with women as we grow.
Shauna Faulisi, Head of Brand